SCHEMBL6094472

SCHEMBL6094472

Cn1c(N2CCCCS2(=O)=O)nc(C(=O)O)c(OCc2ccccc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCA P06881 6/20 0.42
CYP1A2 P05177 3/20 0.38
PTGER1 P34995 1/20 0.38
POLB P06746 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 2/20 0.36
PKM P14618 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6093334 0.90 CALCA (0.39) CALCACYP1A2PTGER1ALDH1A1LMNA
SCHEMBL6093579 0.82 POLB (0.36) CALCAPOLB
SCHEMBL5310259 0.79 CYP1A2 (0.41) CYP1A2ALDH1A1CYP2C9CYP2C19CYP3A4
SCHEMBL1671403 0.78 DPP4 (0.47) CYP1A2ALDH1A1CYP2C19HSD17B10LMNA
SCHEMBL6096728 0.76 ERCC1 (0.38) CALCAPOLB
SCHEMBL3420229 0.75 CYP1A2 (0.47) CYP1A2POLBALDH1A1CYP2C9CYP2C19
SCHEMBL4397474 0.75 CYP1A2 (0.41) CYP1A2PTGER1ALDH1A1CYP2C9CYP2C19
SCHEMBL6086918 0.74 PTPN11 (0.43) CYP1A2ALDH1A1CYP2C9CYP2C19CYP3A4
SCHEMBL6086308 0.74 CRBN (0.41) CYP1A2
SCHEMBL1668866 0.73 HDAC1 (0.46) CYP1A2POLBALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135467-B2 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-14 US disclosed
US-20040204498-A1 HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204498-A1 HIV integrase inhibitors IMPDH1, TYMP, REV1 CALCA 4716/4885CYP1A2 472/4885PTGER1 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.